Bayer logo
Bayer
BAYRY | OTC
Chart Builder DCF Calculator
$15.61
-$0.05 (-0.32%)
At close: Nov 16, 2026, 3:59 PM ET
$15.60
-$0.01 (-0.06%)
After-hours: Nov 16, 2026, 4:00 PM ET

Bayer Company Profile

Company profile explained

Company Profile

Bayer Aktiengesellschaft, commonly known as Bayer AG, functions as a prominent global life sciences company through its various subsidiaries. Its extensive operations are strategically segmented into Pharmaceuticals, Consumer Health, and Crop Science. The Pharmaceuticals division concentrates on developing and marketing prescription medications, with key areas including cardiology and women's healthcare. It also offers specialized therapeutic solutions for oncology, hematology, and ophthalmology, alongside diagnostic imaging equipment, contrast agents, and advanced cell and gene therapies. Bayer's Consumer Health segment provides a wide array of non-prescription (over-the-counter) medicines, medical devices, medicated skincare items, and nutritional supplements. These self-care products address diverse health needs such as dermatology, dietary support, pain relief, cardiovascular risk prevention, digestive issues, allergy management, and cold and cough symptoms. The Crop Science division supports the agricultural sector with chemical and biological crop protection products, genetically enhanced plant traits, seeds, digital farming tools, and solutions for pest and weed control. This segment also manages the breeding, propagation, production, and specialized treatment of seeds, complemented by dedicated customer service for farmers. Bayer is actively involved in numerous strategic collaborations to bolster its research and development pipeline. These partnerships include an agreement with MD Anderson Cancer Center for oncology drug development, a research and licensing deal with Dewpoint Therapeutics, Inc. focused on novel treatments for cardiovascular and gynecological diseases, and collaborations with Exscientia Ltd, Foundation Medicine Inc., Evotec AG, and Arvinas Inc. Additionally, the company maintains strategic research alliances with the University of Oxford for gynecological therapies and with Kyoto University to discover potential new drugs for pulmonary conditions. The company’s products reach a broad market through various distribution channels, including wholesale partners, independent and chain pharmacies, supermarkets, online and other retail outlets, hospitals, and direct sales to agricultural producers. Bayer Aktiengesellschaft was established in 1863 and is headquartered in Leverkusen, Germany.

Key Executives

Name Position
William N. Anderson Chairman of the Management Board & Chief Executive Officer
Alex Buschermohle Chief Information Officer, Head-Digital Transformation & IT-Crop Science Division
Judith Hartmann Chief Financial Officer & Member of Management Board
Bill Dodero General Counsel and Senior Vice President of Law Patents & Compliance
Heike Prinz Chief Talent Officer, Labor Director & Member of Management Board
Jana Marlen Ackermann Head of the Investor Relations
Julio Triana Member of Management Board & President of Consumer Health Division
Michael Preuss Head of Communications, Government Relations and Corporate Brand
Rodrigo Santos Member of Management Board, Head of the Crop Science Division & President of Crop Science Division
Stefan Oelrich President of the Pharmaceuticals Division & Member of the Board of Management
Bayer
Bayer logo
Country Germany
IPO Date Nov 18, 1996
Industry Drug Manufacturers - General
Sector Healthcare
Employees 88,078
CEO Bill Anderson

Contact Details

Kaiser-Wilhelm-Allee 1 Leverkusen, NW 51368 Germany

Stock Details

Ticker Symbol BAYRY
Exchange OTC
Fiscal Year n/a
Reporting Currency USD
CIK Code n/a
CUSIP Number 072730302
ISIN Number US0727303028
SIC Code n/a

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.